This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Sharing a Breath: Interdisciplinary Management of Patients With Severe Asthma

Sharing a Breath: Interdisciplinary Management of Patients With Severe Asthma

Format

Slide Lecture Series

Time to Complete

1.00 hour

Released

September 30, 2019

Expires

September 30, 2020
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 CreditTM
1.00 / CE for Nurses
1.00 / CE for Nurse Practitioners (0.10 pharmacology credit)

Accredited Provider

This activity is jointly provided by Global Education Group and Integritas Communications.

Commercial Supporter

This activity is supported by an educational grant from AstraZeneca Pharmaceuticals LP.

Program Description/Statement of Need

This program is designed to provide primary care providers (PCPs) with education on the assessment of asthma in patients—with an emphasis on recognizing severe asthma—when specialist referral is warranted, and an overview of available advanced treatments for severe asthma. Despite the clear need for comprehensive and intensive management, PCPs are challenged to identify, assess, and coordinate treatment for patients with severe asthma. A pulmonologist and a primary care physician who are experts in asthma management provide practical recommendations for PCPs on how to best assess the severity of a patient’s asthma and evaluate the causes of poor asthma control. Faculty also update PCPs on the quickly evolving treatment landscape and on recommendations on how to monitor for disease progression and treatment responses. Educating patients about their disease, routine use of asthma action plans, and treatment options are other topics important to time-limited PCPs also covered in this program.

Intended Audience

The educational design of this activity addresses the needs of primary care providers (PCPs) involved in the assessment, referral, and multidisciplinary management of severe asthma.

Educational Objectives

Upon completion of this activity, participants will be better prepared to:

  • Identify patients with asthma who should be referred for specialist follow-up based on ongoing symptoms, exacerbation history, and treatment responses
  • Discuss biologic options that have been approved by the US Food and Drug Administration for the treatment of severe asthma
  • Coordinate the management of patients with severe asthma that requires multidisciplinary care to maximize symptom control, reduce exacerbation risks, and minimize medication-related toxicities
  • Educate patients with severe asthma about disease-related risks, long-term treatment options, and information related to adherence and self-management

Conflict Of Interest Disclosure Policy

Global Education Group (Global) requires instructors, planners, managers, and other individuals and their spouses/life partners who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Faculty

Nick A. Hanania, MD
Associate Professor of Medicine
Director, Airways Clinical Research Center
Pulmonary, Critical Care, and Sleep Medicine
Baylor College of Medicine
Houston, Texas

Dr. Hanania discloses the following:
Advisory Board: AstraZeneca, Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, Mylan N.V., Novartis AG, sanofi-aventis U.S. LLC
Honoraria: AstraZeneca, Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, Mylan N.V., Novartis AG, sanofi-aventis U.S. LLC
Research Grants: AztraZeneca, Boehringer Ingelheim International GmbH, GlaxoSmithKline plc

Barbara P. Yawn, MD, MSc, FAAFP
Adjunct Professor
Department of Family and Community Health
University of Minnesota
Minneapolis, Minnesota

Dr. Yawn discloses the following:
Consultant: AstraZeneca, Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, Novartis AG

Planners' and Managers' Disclosures

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME/CE activity:

Ashley Marostica, RN, MSN, has nothing to disclose.
Kristen Delisi has nothing to disclose.
Lindsay Borvansky has nothing to disclose.
Andrea Funk has nothing to disclose.
Liddy Knight has nothing to disclose.
Ashley Cann has nothing to disclose.
Jim Kappler, PhD, has nothing to disclose.
Julia Muino has nothing to disclose

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Integritas Communications. Global is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

Global Education Group designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 CreditTM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.00

Type

CNE Contact Hour(s)

Accreditation Statement

Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Designation Statement

This educational activity for 1.00 contact hour is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.00

Type

CE for Nurse Practitioners

Accreditation Statement


This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through joint providership of Global Education Group and Integritas Communications. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121.

Activity ID #2926E

This activity was planned in accordance with AANP CE Standards and Policies.

Designation Statement

This activity is approved for 1.00 contact hour which includes 0.10 hour of pharmacology.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Global and Integritas Communications do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Fee and Refund / Cancellation Policy

There is no fee for this educational activity.

Instructions

In order to receive credit, participants must complete the pre-assessment questions, view the activity in its entirety, and complete the posttest and program evaluation. Participants must also score at least 100% on the posttest. You will receive a digital copy of your credit certificate at the conclusion of the activity. Your online certificate will be saved on myCME within your Profile/Exam History, which you can access at any time.

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com

If you have any other questions relating to your certificate or other issues with the activity, please contact
myCME.Support@haymarketmedical.com.

Privacy Policy

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue